AzTrials
AzTrials

Post-Intensive Care SyndromeIMPRESSNCT06118606

Pilot Study of a Multidisciplinary Intervention in ICU Survivors at Risk for Psychological or Physical Morbidity

A study testing Case-manager led multidisciplinary follow-up after intensive care in people with Post-Intensive Care Syndrome and Depressive Symptoms, run by Region Stockholm at 2 sites in Sweden.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Pilot study of the feasibility and utility of an early, in-hospital multidisciplinary intervention in ICU survivors at risk for psychological and physical problems post-ICU stay Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Case-manager led multidisciplinary follow-up after intensive care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
2 sitesSweden
Study dates
1 Feb 2024to 30 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients admitted ≥12 hours to the ICU with an increased risk for physical or psychological sequelae (assessed with the PROGRESS-ICU/PREPICS instruments)

Who cannot join

  • Dementia or other major cognitive problems
  • Structural brain or spinal cord injury
  • Multiple limitations of medical treatment
  • Insufficient language skills (Swedish)

Trial locations and contacts

2 sites in 1 country.

Sweden2 sites
  • ICU Karolinska University Hospital

    Stockholm, 113 45

  • ICU Södersjukhuset

    Stockholm

Other trials in Sweden

About this study

Official title: Interventional Multidisciplinary Rehabilitation and Special Support; a Pilot Study of a Case Manager-led Multidisciplinary Intervention in ICU Survivors at Risk for Psychological or Physical Morbidity -IMPRESS-ICU Pilot Study

Pilot study of the feasibility and utility of an early, in-hospital multidisciplinary intervention in ICU survivors at risk for psychological and physical problems post-ICU stay

Read the detailed description

60 adult patients at two hospitals in Region Stockholm (Karolinska University Hospital and Södersjukhuset) with an ICU stay ≥12 hours with increased risk for psychological/physical sequelae will be invited to participate.

Intervention: Early re-assessment and multidisciplinary follow-up, led by an ICU follow-up staff (Case Manager, CM). The CM will support the patient and coordinate the rehabilitation efforts from ICU discharge to primary care with a secondary, deepened assessment of symptoms in the ward, recapitulation and information about the time spent in the ICU, followed by a multidisciplinary discussion with concerned specialists and the set-up of an individual rehabilitation plan communicated to the patient and the informal caregivers. The CM will keep track of the patient during hospital stay and ensure that there is a plan for further primary care rehabilitation after hospital discharge. The CM will contact the patient weekly to follow up on wellbeing and planned primary care activities until 12 weeks. At twelve weeks, patients will be assessed with regards to psychological symptoms (HADS, PTSS-14) and physical disability (BI).

Outcome: The primary outcome is the feasibility of the intervention. Patients and informal caregivers will be invited to participate in semi-structured interviews that will deepen the knowledge about their views upon the intervention, needs and suggested measures to improve the patients' recovery. Resource utilisation will be documented by the CM and feedback collected from involved ICU staff and hospital clinicians. Secondary outcomes are patients' level of psychological and physical problems and health-related quality of life. The results from the pilot study will inform a subsequent randomized controlled trial of an early follow-up intervention.

Being tested
Case-manager led multidisciplinary follow-up after intensive care
Keywords
Post-intensive care syndrome, Pilot study, Early follow-up intervention
Medical subject headings
postintensive care syndrome, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Case-manager led multidisciplinary follow-up after intensive careOther

    Early in-hospital follow-up in survivors of intensive care with an increased risk of psychological/physical sequelae. The follow-up is led by a case-manager reassessing the patient after ICU discharge for psychological/physical rehabilitation needs. The CM will discuss patient needs with concerned specialists in a multidisciplinary team, leading to the establishment of a personal rehabilitation plan, communicated to the patient and next-of-kin. The CM will keep track of the patient during hospital stay and ensure primary care rehabilitation (if needed) is established once the patient is discharged from the hospital. The CM will contact the patient weekly to follow up on well-being and primary care activities until 12 weeks after discharge.

Study groups in NCT06118606
Study groupRoleWhat they receive
Interventional armExperimentalIntervention arm
Receives: Other: Case-manager led multidisciplinary follow-up after intensive care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the intervention

    Evaluation of the method including resource utilization with involved ICU follow-up staff/case managers and patients and their informal caregivers.

    Measured: Outcome measured during and after termination of data collection and end of intervention

  2. Utility of the intervention

    Patient and caregiver views on the intervention's utility. Views on the intervention from hospital ward staff.

    Measured: Outcome measured three-four months after ICU discharge

Secondary outcomes (5)
  1. Depressive symptoms post-ICU

    Assessment of patients' symptoms of depression post-intervention

    Measured: Outcome measured three months after ICU discharge

  2. Anxiety symptoms post-ICU

    Assessment of patients' symptoms of anxiety post-intervention

    Measured: Outcome measured three months after ICU discharge

  3. Symptoms of post-traumatic stress post-ICU

    Assessment of patients' symptoms of post-traumatic stress post-intervention

    Measured: Outcome measured three months after ICU discharge

  4. Physical disability post-ICU

    Assessment of physical performance post-intervention

    Measured: Outcome measured three months after ICU discharge

  5. Health-related quality of life post-ICU

    Health-related quality of life (HRQL) assessed with the RAND-36 questionnaire, scoring 0-100 where a higher score indicates greater HRQL.

    Measured: Outcome measured three months after ICU discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2023
  2. Study start1 Feb 2024
  3. Primary completion30 Mar 2025
  4. Study completion30 Mar 2025

Why it stopped: For logistical reasons at one study site.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Pilot study of the feasibility of the intervention
Masking
None (open label)
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06118606
Sponsor's protocol ID
2022-03436-01
Acronym
IMPRESS
Status last verified
Oct 2024
First submitted
1 Nov 2023
Last updated
13 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Case-manager led multidisciplinary follow-up after intensive care in people with Post-Intensive Care Syndrome and Depressive Symptoms, run by Region Stockholm at 2 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: For logistical reasons at one study site.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the intervention (time frame: Outcome measured during and after termination of data collection and end of intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in